glp-1 drugs pharmaceutical companies news 2025 GLP1 agonists set to become the best-selling in 2024: GlobalData 2025 Pharmacy in Focus Report:

US$ 20.66

★★★★★ 4.1 (7 reviews)

US$ 22.30

★★★★★ 4.1 (11 reviews)

US$ 23.01

★★★★★ 4.2 (16 reviews)

US$ 26.81

★★★★★ 4.0 (22 reviews)

US$ 23.29

★★★★★ 4.2 (17 reviews)

US$ 28.54

★★★★★ 4.4 (15 reviews)

US$ 27.67

★★★★★ 4.0 (20 reviews)

US$ 21.35

★★★★★ 4.9 (14 reviews)

US$ 27.65

★★★★★ 4.7 (23 reviews)

US$ 26.62

★★★★★ 4.3 (5 reviews)

US$ 24.85

★★★★★ 4.2 (29 reviews)

US$ 24.56

★★★★★ 4.0 (14 reviews)

US$ 25.02

★★★★★ 5.0 (23 reviews)

US$ 27.33

★★★★★ 4.6 (20 reviews)

US$ 27.85

★★★★★ 4.4 (13 reviews)

US$ 26.52

★★★★★ 4.6 (6 reviews)

US$ 26.10

★★★★★ 5.0 (13 reviews)

US$ 27.81

★★★★★ 4.5 (29 reviews)

US$ 29.01

★★★★★ 4.0 (17 reviews)

US$ 24.31

★★★★★ 4.4 (5 reviews)